MedCity News

Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs

Walgreens Introduces Virtual Weight Management Offering

Walgreens launched a virtual weight management program offering clinician support and GLP-1 prescriptions for self-pay patients.

By Marissa Plescia

BioPharma, Artificial Intelligence

Generate Biomedicines’ IPO Brings In $400M for Pivotal Tests of Severe Asthma Drug

Flagship Pioneering-founded Generate Biomedicines aims to offer less frequent injections compared to a blockbuster asthma drug from partners Amgen and AstraZeneca. Generate’s drug comes from a “programable biology” platform technology that uses AI and machine learning to design proteins with desirable properties.

By Frank Vinluan

MedCity Influencers

Where the Patient Experience Is Heading – And 3 Ways Healthcare Providers Can Meet That Moment

Healthcare providers need to be thinking not only about the experience that patients need and want now, but the experience they’re going to need and want down the road.

By Jaeson Paul

Latest Video

Latest News

MedCity Influencers

A human hand interacts with an artificial intelligence robotic hand with medical icons and a digital interface on dark background, illustrating healthcare technology AI trust

Regulating Healthcare AI? Look To E-Prescribing

Any regulations applied won’t be as simple as putting on a Band-Aid and forgetting about future problems. To regulate appropriately, we need to learn from the past and act quickly as AI is rapidly incorporated into healthcare.

By Michael Blackman

Artificial Intelligence, Health Tech, Payers

How Elevance Health Is — and Isn’t — Using AI

Ratnakar Lavu, Elevance Health’s chief digital information officer, said the company is using AI to streamline approvals, claims processing and member support while keeping denials under human review.

By Katie Adams

BioPharma, Pharma

FDA Voucher Leads to Speedy Approval of Boehringer Drug for First-Line Use in Lung Cancer

The label expansion for Boehringer Ingelheim’s Hernexeos was made under an FDA pilot program that accelerates regulatory review of products with national interest. The daily pill is now approved as a first-line treatment for HER2-positive non-small lung cancer, an indication with few treatment options.

By Frank Vinluan

Health Tech

Collective Health Collaborates with Google Cloud to Launch New AI-Powered System

Collective Health partnered with Google Cloud to launch an AI-powered system that helps members navigate benefits and streamlines plan administration for employers.

By Marissa Plescia

BioPharma

Boehringer Boosts Pipeline, Adding Oral Small Molecules With Broad Immunology & Inflammation Potential

Boehringer Ingelheim receives rights to oral small molecules from Sitryx with potential applications in multiple autoimmune disorders. Depending on the progress of Boehringer’s research, Sitryx could receive more than $500 million.

By Frank Vinluan

MedCity Influencers

multiple balls balancing showing vendor risk

Compliance: Why Your Vendor’s Vendor is a Growth Risk

The core challenge for leadership is no longer merely managing direct vendors; it’s the cascading risk of the "nth-party" supplier.

By Girish Redekar

MedCity Influencers

Rare Disease Day 2026: From Awareness to Access in a Volatile Year for Patients and Specialized Therapies

It's not just about awareness but also a call to action for patients, families, employers, payers and policymakers to modernize the systems that shape access to care. It must focus on connecting innovation with the infrastructure that governs approval, coverage and affordability.

By Donovan Quill

MedCity Influencers

HR1 Is Stress Testing Medicaid Performance Metrics and Exposing a Failure in Engagement

This disconnect has become one of the defining operational challenges facing Medicaid plans. What was once considered an under-the-radar risk is no longer subtle. It is now actively shaping plan performance, provider behavior, and financial outcomes across Medicaid systems.

By Scott H. Schnell

Hospitals, Providers

After 4-Week Strike, Kaiser Permanente Workers Score Tentative Win on Staffing & Pay

About 31,000 Kaiser Permanente workers ended a four-week strike after reaching a tentative agreement that includes measures to address chronic understaffing and wage increases. The full contract has not yet been ratified.

By Katie Adams

Policy

How Healthcare Leaders Responded to Trump’s State of the Union

Some healthcare experts supported Trump’s comments on lowering prescription drug costs, while others criticized his remarks on health coverage.

By Marissa Plescia

Artificial Intelligence, Startups, BioPharma

Novo Nordisk Commits Up to $2B to Drug Delivery Startup Vivtex for R&D of Oral Metabolic Meds

Vivtex’s technology uses AI and high throughput screening to identify the combinations of drug ingredients that can deliver peptides through gastrointestinal tissue. Besides Novo Nordisk, the MIT spinout’s partners include Astellas Pharma, Equillium, and Orbis Medicines.

By Frank Vinluan

MedCity Influencers

Digital generated image of dollar sign lying on a medical couch visualizing crisis and loss.

AI-Driven Coding is Driving Costs Up. How Can Payers Adapt?

As AI-enabled coding increasingly adjudicates and reimburses claims on the first pass, often at higher levels, payers face a growing challenge: traditional cost-containment mechanisms are unable to keep pace.

By Liz Levy

MedCity Influencers

Making Quality a Daily Habit

Sustainable quality doesn’t live in binders or dashboards; it lives in the small, repeatable actions that happen every day.

By Deb Jones